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Summary.-A rat mammary carcinoma induced by 7-12 dimethylbenzanthracene
was seriallytransplanted into successive generations ofthymectomized host animals.
After its 2nd passage, the growth of the tumour appeared hormone-dependent,
regressing after oophorectomy and regrowing with administration of oestradiol 17P
to the host. Third-generation transplanted tumours, however, showed only a tran-
sient regression after oophorectomy, and the growth of tumours after further
passages appeared ovary-independent. Loss in hormone dependency was not
accompanied by histological changes. There was however a progressive increase
with successive transplantation in the ability of tumours to metabolize7(Y.[3H] testo-
sterone in vitro. This was accounted for by raised conversion to 5(x androstanediol.
RAT MAMMARY TUMOURS induced by the
carcinogen 7-12 dimethylbenzanthracene
(DMBA) have been shown to metabolize
testosterone, primarily by 5cx reduction,
an activity which may be influenced by
hormones both in vitro (Miller, 1976a) and
in vivo (Miller, 1976b,c; Buchan et al.,
1976). The growth of most DMBA-
induced tumours is hormone-dependent.
In the study reported in this paper a rat
mammary tumour, originally induced by
DMBA, has been transplanted into suc-
cessivegenerations ofhost animals. Effects
of transplantation on hormone depen-
dence and tumour metabolism of testo-
sterone have been investigated.
MATERIALS AND METHODS
Animal&-All animals used were of an
inbred strain of Sprague-Dawley rat, ob-
tained from the Animal Diseases Research
Association (ADRA), Moredun Institute,
Edinburgh.
Tumour line.-The line (TG5) was derived
from a mammary tumour induced in a female
ADRA rat by i.v. administration of 5 mg
DMBA at 50 days of age. A portion of this
primary tumour was cut into Imm cubes in
Hartmann-Ringer lactate solution. These
were aspirated into a narrow-bore cannula
using a syringe and then implanted through
a small skin incision on to the back of neo-
natally thymectomized host animals. Once
established, these tumour transplants were
classified TG 5/1. Successive generations of
tumour were transplanted in the same way
and classified TG 5/n, where n represents the
number ofpassages.
Experimentalprotocol.-Except for TG 5/1,
'"Thich was established inonly a single animal,
each tumour generation was studied in 4
animals. Two animals were killed without
having received endocrine manipulation, and
the tumours removed.
The remaining 2 rats were bilaterally
oophorectomized and 10 days later given
daily injections of oestradiol 17g (I .ug in
0-2 ml corn oil) for a further 10 days, when
the animals were killed and the tumours
removed. Tumours were measured '",ith
calipers on alternatedays from whenpalpable
until death. Size wasexpressed as theproduct
of 2 diameters at right angles in CM2.
Tumour -steroid metaboli8M.-A portion of
each tumour (0-5g) wasfinely sliced in Krebs-
Ringer phosphate buffer, pH 7-4 (5 ml). An
NADPH-generating system and 20 .Xi
[7(x3H] testosterone was added and the
systems incubated for I h at 37T in anSERIAL PASSAGE OF A MAMMARY CARCINOMA
atmnosphere of 02. Reaction was halted by
addition of methanol (30 ml) and the incuba-
tions stored at -10°C until the metabolites
were characterized by the methods previously
described (Miller et al., 1974). Metabolism and
conversion of testosterone were determined
by measuring radioactive label in the appro-
priate metabolites. Estimation of 5a reduc-
tion was obtained by combining the produc-
tion of 5a-dihydrotesterone with that of 5o-
androstanediol.
DNA estimation. Tumour DNA content
was determined by a modification of the
method of Burton (1956).
RESULTS
Tumour growth
The effect of endocrine manipulation
was not studied in the primary DMBA-
induced tumour or at its initial trans-
plantation. Pattern of growth following
oophorectomy and subsequent oestrogen
administration is, however, shown in the
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Figure for tumours at their 2nd, 3rd, 4th
and 7th passages. Tumours at their 2nd
passage (TG 5/2) regressed after oophor-
ectomy, but regrew on administration of
oestradiol. Oophorectomy ofanimals bear-
ing TG 5/3 tumours produced only trans-
ient tumour regression, and the size 10
days after oophorectomy exceeded that
before ablation. In contrast the growth of
TG 5/4 tumours appeared not to be
affected by oophorectomy though there
was evidence for accelerated growth once
oestrogen was administered. All subse-
quent generations oftransplanted tumours
responded in this way to endocrine
manipulation.
Tumour histology
No obvious change in tumour histology
wasseenduring successive transplantation,
and fibrosarcomatous development which
can appear during transplantation (Horn
et al., 1976) was not evident.
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TABLE I.-Metabolism of [7a3H] testosterone by TG 5 transplanted tumoursfrom endocrine
unmanipulated animals
Transplant DNA content
generation (mg/g tumour)
TG 5/1
TG 5/2
TG 5/3
TG 5/4
TG 5/7
5-89
6-08
6-40
7 00
5-23
7-26
5-52
5-17
4-46
% Testosterone
metabolized
38-30
41-62
31-68
59 05
51-96
68-62
74-18
71-89
74-25
%5(X
% 5ctDHT Androstanediol
produced produced
10-54
7-34
7-24
9-14
7-65
10-97
9-87
17-70
14-46
23-07
23-47
20-83
4007
36-67
52-09
59.94
51-41
55-20
TABLE II.-Metabolism of [7cc3H] testosterone byTG 5 transplanted tumnoursfrom
endocrine-ablated, oestrogen-treated animals
Transplant
generation
TG 5/2 (a)
(b)
TG 5/3 (a)
(b)
TG 5/4 (a)
(b)
TG 5/7 (a)
(b)
DNA content
(mg/g tumour)
5 03
4-65
4-26
4-28
4 30
4 30
5 19
4-35
% Testosterone
metabolized
49-89
43-25
53 40
57-62
69-71
69-80
66-90
70 57
Tumour steroid metabolism
The results from incubations oftumours
with 7ox3H testosterone are presented in
Tables I and II. In all tumours, 5oreduc-
tion of testosterone to 5aodihydrotesterone
and 5afandrostanediol accounted for most
ofthe metabolism. In tumours from endo-
crine-unmanipulated animals (Table I)
transformation oftestosterone wasroughly
similar in TG 5/1 and TG 5/2 tumours.
However, metabolism was higher in
tumours from the TG 5/3 generation, and
a further raised level of metabolism was
noted in TG 5/4 and TG 5/7 tumours. This
change in metabolism with successive
transplantation was accounted for by a
parallel increase in 5ct reduction of testo-
sterone, this being particularly evident in
the conversion to 5oaandrostanediol. Re-
sults in tumours from animals after endo-
crine procedures are shown in Table II. A
similar but less marked trend ofincreasing
metabolism and 5a reduction of testo-
sterone with successive generations of
% 5aDHT
produced
12-74
9 04
12-43
12-79
9.54
15-21
7-12
12-90
% 5cr-
Androstanediol
produced
30-27
30-60
34-58
38-15
50 50
41-72
48-64
50*55
5cx reduction
42-81
39-64
47-01
50 94
60-04
56-93
55-76
60-45
tumours was evident. No progressive
changes in tumour DNA content were ob-
served with serial passage in either endo-
crine-manipulated or unmanipulated ani-
mals.
DISCUSSION
The TG5 rat mammary tumour line was
derived from a tumour induced by DMBA
in a female Sprague-Dawley rat. No infor-
mation is available on the hormone de-
pendence of this primary tumour or its
1st-generation transplant, but at 2nd
passage the growth of the tumour ap-
peared hormone-dependent, regressing
after oophorectomy. With successive
transplantation, however, the tumour
first showed only transient regression
(TG5/3) and then no regression after
oophorectomy (TG 5/4 onwards). Similar
changes after transplantation in tumour
growth pattern from ovary-dependent to
ovary-independent have been reported in
other transplantable rat mammary tum-
5Scx reduction
33-61
31-81
28-07
49-21
44-32
63-06
68-81
69-11
69-66
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ours (De Sombre et al., 1976; Horn et al.,
1976). Whilst later generations of trans-
plantable tumours do not regress after
oophorectomy, they may retain some
degree of sensitivity to hormones (Hilf,
1972). In the present study the growth of
TG 5/4 and TG 5/7 tumours, though not
influenced by ovarian ablation, appears
to be stimulated by administration of
oestrogen to oophorectomized animals.
Although oestrogen-receptor activity was
detectable in cytosols from TG 5/7
tumours (mean receptor level 3-4 fmol/mg
protein, Kq 0 45 x 10-10M) the levels were
much lower than in DMBA-induced hor-
mone-dependent rat mammary tumours
(Hawkins et al., 1978).
In addition to determining the effects of
tranplantation on tumour endocrine re-
sponse, successive generations of tumours
have been examined for their ability to
metabolize testosterone in vitro. In all
generations of tumours studied, 5a-re-
duced products were the major metabo-
lites of testosterone. However, with suc-
cessive transplantation there was an
increase in tumour metabolism and 5aS
reduction of testosterone, such that there
was a doubling of 5az reduction between
TG 5/1 and TG 5/7 tumours taken from
endocrine-unmanipulated animals.
Scandrostanediol (3oa 178) appeared to
be the metabolite most consistently
affected and it may be that the effects of
5ox reduction are secondary to those on
3oihydroxysteroid dehydrogenase. How-
ever, under the incubation conditions
used, 5acandrostanediol was the single
greatest Sc reduced product identified,
and effects on 5af reduction are most
likely to be evident in this metabolite. A
similar but smaller rise in 5a reduction
with increasing number of passages was
evident in endocrine-treated animals.
Endocrine manipulation itself has been
shown to influence 5oa reduction in these
tumours: oophorectomy increases the
activity and oestrogen administration to
oophorectomized animals decreases the
5a, reduction (Miller et al., 1979). The
effects of oestrogen administration can,
however, be variable, and this may have
masked the full effects of transplantation.
It is tempting to speculate that the
changes in testosterone metabolism are
linked with the transition of tumour
hormone dependency. Metabolism in TG
5/2 tumours, which regress after oophor-
ectomy, and TG 5/1 tumours is similar and
much lower than in TG 5/4 and TG 5/7
tumours, which do not regress after
oophorectomy. Tumours of the TG 5/3
generation, which only show transient
regression after oophorectomy, have inter-
mediate metabolism. It is interesting
therefore that in the mouse 5a, reduction
of testosterone is lower in androgen-
dependent mammary tumours than in
these which are independent (Yamaguchi
et al., 1974). Although no significant
difference in steroid metabolism was de-
tected between hormone-dependent and
independent DMBA-induced rat mam-
mary tumours (King et al., 1965) endo-
crine-treated animals were used and in the
present study effects in such animals were
more difficult to detect than in un-
manipulated animals. Furthermore the
levels oftumour 5ct reduction were at least
10-fold less (King et al., 1964) than those
reported in the system used in the present
study. It is possible that the apparent
relationship detected in this study be-
tween hormone dependence and steroid
metabolism is only causal and that some
other feature oftransplantation has caused
the observed increase in testosterone
metabolism.
Difference in tumour growth rate is
unlikely, as all tumours were actively
growing at the time of study. A simple
increase in tumour cellularity is also un-
likely, because there was no evidence for
an increase in tumour DNA content or
histology with transplantation. However,
a general increase in cellular metabolism
cannot be excluded, and no information is
available on the metabolism of other
steroid precursors.
Until the specificity of the changes in
steroid metabolism is further defined, the
physiological relevance of these effects
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must remain in doubt. However, to the
author's knowledge this is the first docu-
mented observation that successive trans-
plantation may affect tumour steroid
metabolism. That a change in tumour
hormone dependence occurs concurrently
and the steroid conversion involved is one
which may be hormonally influenced
(Miller, 1976a,b,c; Buchan et al., 1976)
gives added interest to the findings.
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